Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.9289
+0.0119 (1.30%)
At close: Oct 28, 2025, 4:00 PM EDT
0.9250
-0.0039 (-0.42%)
Pre-market: Oct 29, 2025, 7:44 AM EDT
Longeveron Revenue
Longeveron had revenue of $316.00K in the quarter ending June 30, 2025, a decrease of -32.48%. This brings the company's revenue in the last twelve months to $2.07M, up 68.67% year-over-year. In the year 2024, Longeveron had annual revenue of $2.39M with 237.38% growth.
Revenue (ttm)
$2.07M
Revenue Growth
+68.67%
P/S Ratio
6.56
Revenue / Employee
$82,920
Employees
25
Market Cap
19.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.39M | 1.68M | 237.38% |
| Dec 31, 2023 | 709.00K | -513.00K | -41.98% |
| Dec 31, 2022 | 1.22M | -84.00K | -6.43% |
| Dec 31, 2021 | 1.31M | -4.32M | -76.80% |
| Dec 31, 2020 | 5.63M | -10.47K | -0.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
LGVN News
- 1 day ago - Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR's BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome (HLHS), a Rare Pediatric Congenital Heart Defect - GlobeNewsWire
- 22 days ago - Longeveron® to Participate in the 4th Annual ROTH Healthcare Opportunities Conference - GlobeNewsWire
- 5 weeks ago - Longeveron® to Attend Alliance for Regenerative Medicine's Cell & Gene Meeting on the Mesa - GlobeNewsWire
- 7 weeks ago - Longeveron® Announces Key Leadership Updates - GlobeNewsWire
- 2 months ago - Longeveron® to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 2 months ago - Longeveron Inc. (LGVN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Longeveron® Announces Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Longeveron Announces Closing Of Up To $17.5 Million Public Offering - GlobeNewsWire